Peripheral arterial occlusive disease during ponatinib therapy after failure of imatinib: a case report-Reference-Cited by-同舟云学术

Peripheral arterial occlusive disease during ponatinib therapy after failure of imatinib: a case report

Published:2016-03-23 Issue:3 Volume:41 Page:360-361
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Tournaire G.¹,Despas F.²,Huguet F.³,Montastruc J. L.¹,Bondon-Guitton E.¹

Affiliation:

1. Service de Pharmacologie Médicale et Clinique; Centre Midi-Pyrénées de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, Pharmacopôle Midi-Pyrénées; Faculté de Médecine de l'Université de Toulouse; Centre Hospitalier Universitaire de Toulouse; Toulouse France

2. Service de Pharmacologie Médicale et Clinique; Faculté de Médecine de l'Université de Toulouse; Centre Hospitalier Universitaire de Toulouse; Toulouse France

3. Service d'Hématologie; Institut Universitaire du Cancer; Toulouse France

Funder

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12383/fullpdf

Reference6 articles.

1. Ponatinib in refractory Philadelphia chromosome-positive leukemias;Cortes;N Engl J Med,2012

2. A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias;Cortes;N Engl J Med,2013